This HTML5 document contains 139 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34613161
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel 2009年論文 artigo científico (publicado na 2009) мақолаи илмӣ videnskabelig artikel (udgivet 2009) artículu científicu espublizáu en 2009 ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tieteellinen artikkeli article scientific 2009년 논문 مقالهٔ علمی 2009 nî lūn-bûn 2009年论文 artikull shkencor artículo científico publicado en 2009 научни чланак bài báo khoa học articol științific mokslinis straipsnis naučni članak scientific article article científic 2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած 2009年论文 מאמר מדעי научная статья 2009年論文 artigo científico artykuł naukowy teaduslik artikkel 2009年の論文 vedecký článok tudományos cikk 2009年论文 2009年论文 vetenskaplig artikel vitenskapelig artikkel scienca artikolo مقالة علمية научни чланак სამეცნიერო სტატია 2009年論文 научна статия 2009年論文 наукова стаття, опублікована в жовтні 2009 article scientifique (publié 2009) vitskapeleg artikkel articolo scientifico 2009 թվականի հոտեմբերին հրատարակված գիտական հոդված 2009年论文 bilimsel makale wissenschaftlicher Artikel επιστημονικό άρθρο vědecký článek artigo científico (publicado na 2009) мақолаи илмӣ artikulong pang-agham บทความทางวิทยาศาสตร์ سائنسی مضمون 2009年论文 2009年論文
p:P577
wds:Q34613161-6F6DCE87-C940-47A1-B2C7-F7BB46009220
wdt:P577
2009-10-26T00:00:00Z
p:P407
wds:Q34613161-15B066EE-A830-4148-B288-DBEB49813C13
wdt:P407
wd:Q1860
p:P2093
wds:Q34613161-44EF8381-D75F-4042-B914-4CD3755351E4 wds:Q34613161-350A22C0-2AA6-491C-B1B1-EF99943416FE wds:Q34613161-1727421E-404A-4805-8476-9015BB3E50B0 wds:Q34613161-1064B093-6003-4455-99C6-F80CD88A51ED wds:Q34613161-0F934550-05B0-4851-AFF3-D3F6E89B27DD wds:Q34613161-E8A6B3E3-826F-4D28-A7E8-5486901F11D5 wds:Q34613161-E7238F4A-7A0E-488B-A218-128268E95EA2 wds:Q34613161-E8883BDA-2190-4A53-89E7-9F54580179B5 wds:Q34613161-E48C9D79-AA7A-4A35-931B-5D7CD7E52765 wds:Q34613161-D3D153CC-3E19-42EE-9DAD-717398198B1B wds:Q34613161-E27D8B65-8C31-48AC-9088-B8D02472594B wds:Q34613161-B7817F9F-DA14-4F41-9F65-DFFC02BFD4D0 wds:Q34613161-9903351D-C6C0-47E2-BD60-53D49C4768DB wds:Q34613161-9B566EED-B81F-425E-9C5E-08C27545D6CE wds:Q34613161-7D460053-3808-421D-9A35-65DACE59FCB3 wds:Q34613161-5FD8C878-AE1B-4C97-8863-6FD3FE9381B9
wdt:P2093
Julia West Adrian Crellin Stephen Falk Pauline Leonard William Steward Ian Chau Fawzi Adab Richard Herrmann Deborah D Stocken Peter G Harper Martin Eatock Joyce Thompson Joe Ostrowski Catrin Tudur-Smith Werner Scheithauer David Smith
rdfs:label
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer
skos:prefLabel
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer
schema:name
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer
p:P50
wds:Q34613161-8E34D27E-B378-4997-A08C-11C58E7B9D2A wds:Q34613161-32A71E67-B632-45DD-84E0-57F593B9BD12 wds:Q34613161-0D238FCF-F05A-4EF5-B4BD-A76D4482AC0A wds:Q34613161-4449D2A4-FE03-4EB6-AF33-4C281D3618A0 wds:Q34613161-3CF3799B-C649-436E-AF4B-732DD5A16101
wdt:P50
wd:Q105358160 wd:Q39065464 wd:Q56440814 wd:Q38803238 wd:Q37830751
p:P1476
wds:Q34613161-395715CF-52C0-46B5-9AEF-3B163346DFB0
wdt:P1476
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer
p:P304
wds:Q34613161-42899FB2-8426-4832-97B4-E71800C10B3B
wdt:P304
5513-5518
p:P31
wds:Q34613161-068EF132-EF1B-4F36-AC83-B9E769C7F97B
wdt:P31
wd:Q13442814
p:P921
wds:Q34613161-434C4D19-D23D-4838-BD90-868321AB2D17 wds:Q34613161-EA948D3A-E0CA-48BB-82D2-29A6BAFC191A
wdt:P921
wd:Q420207 wd:Q212961
p:P698
wds:Q34613161-9ED6BE28-C904-421B-9DFB-29825DF3295E
wdtn:P698
n10:19858379
wdt:P698
19858379
p:P1433
wds:Q34613161-7DC5F2E3-1188-490D-A7E0-C283B64186DE
wdt:P1433
wd:Q400292
p:P433
wds:Q34613161-71075AE2-73D8-4E70-8AE0-5BD90798B31E
p:P478
wds:Q34613161-E32B7CF5-3B0D-4F65-BFE6-CE679E074257
wdt:P433
33
wdt:P478
27
p:P356
wds:Q34613161-58C1FC94-8FE3-43FE-B0FB-1149D31F6BE9
wdtn:P356
n12:JCO.2009.24.2446
wdt:P356
10.1200/JCO.2009.24.2446